MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer

BACKGROUND: Tumor mutational burden (TMB) could be a measure of response to immune checkpoint inhibitors therapy for patients with colorectal cancer (CRC). MicroRNAs (miRNAs) participate in anticancer immune responses. In the present study, we determined miRNA expression patterns in patients with CR...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiahao, Liu, Haizhou, Zhao, Yang, Luo, Tao, Liu, Jungang, Liu, Junjie, Pan, Xiaoyan, Tang, Weizhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900489/
https://www.ncbi.nlm.nih.gov/pubmed/33634010
http://dx.doi.org/10.3389/fonc.2020.550986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900489/
https://www.ncbi.nlm.nih.gov/pubmed/33634010
http://dx.doi.org/10.3389/fonc.2020.550986

Ejemplares similares